Healthy Returns: RFK Jr.'s Covid vaccine recommendation change could threaten health, access
A wave of outrage is sweeping the scientific and medical world after Health and Human Services Secretary Robert F. Kennedy Jr.'s decision to stop recommending routine Covid-19 vaccines for healthy children and healthy pregnant women.
Kennedy, a prominent vaccine skeptic, on Tuesday said the Covid shot has been removed from the Centers for Disease Control and Prevention's recommended immunization schedule for those groups.
"Last year, the Biden administration urged healthy children to get yet another Covid shot, despite the lack of any clinical data to support the repeat booster strategy in children," Kennedy said in a video on X. He offered no scientific evidence to justify the change to the recommendations.
It's Kennedy's latest move to change and potentially undermine vaccinations in the U.S. since he took the helm at the Department of Health and Human Services, which oversees the federal agencies that regulate and recommend shots.
It comes a week after Food and Drug Administration Commissioner Marty Makary set stricter standards for approving shots for healthy Americans.
Some health experts say the dropped recommendation could have devastating consequences, particularly for pregnant women and their babies.
Both are considered to be at higher risk of severe complications from Covid-19 infections, according to the CDC's website. That can include preterm labor and birth, heart injury, blood clots and kidney damage among pregnant women.
"As ob-gyns who treat patients every day, we have seen firsthand how dangerous COVID-19 infection can be during pregnancy and for newborns who depend on maternal antibodies from the vaccine for protection," Steven Fleischman, president of the American College of Obstetricians and Gynecologists, said in a statement.
He emphasized that "the science has not changed."
"Following this announcement, we are worried about our patients in the future, who may be less likely to choose vaccination during pregnancy despite the clear and definitive evidence demonstrating its benefit," Fleischman said.
Studies have found that Covid-19 vaccination reduces the risk of hospitalization from the virus for pregnant women and infants younger than 6 months.
Fleischman and other experts also raised concerns about whether patients will have access to vaccines following Kennedy's decision. The CDC's recommendation is crucial because it guides insurance plans on which shots to cover at no cost to patients.
Medicare and Medicaid require that the recommended vaccines are free for patients. The Affordable Care Act requires private insurers to cover all vaccines recommended by the CDC's outside committee of vaccine advisors and director. Children without insurance can get free recommended vaccines through the government-run Vaccines for Children Program.
Pfizer and Moderna are charging up to $150 per dose for their respective Covid shots before insurance, according to the CDC's website.
"This decision could make it significantly harder for millions of Americans to access vaccines they want for themselves and their families," Tina Tan, president of the Infectious Diseases Society of America, said in a statement.
Tan added that process for Kennedy's decision breaks with the precedent of letting federal panels of experts publicly debate scientific evidence and vote on immunization practices. A group of external advisors to the CDC typically gives vaccine advice to the agency's director.
Trump's nominee to lead the CDC, acting director Susan Monarez, still needs Senate confirmation.
"This decision bypasses a long-established, evidence-based process used to ensure vaccine safety and ignores the expertise of independent medical experts, including members of CDC committees who are examining the evidence regarding the vaccine to make recommendations for the fall," Sean O'Leary, chair of the American Academy of Pediatrics Committee on Infectious Diseases, said in a statement.
He added that the decision could "strip families of choice," preventing those who want to vaccinate from getting shots.
Feel free to send any tips, suggestions, story ideas and data to Annika at annikakim.constantino@nbcuni.com.
Did you hear that? That was the sound of the digital health sector breathing a collective sigh of relief.
Digital physical therapy company Hinge Health debuted on the New York Stock Exchange last week in the sector's first major public exit in several years.
The broader tech IPO market has been in a drought since late 2021, when soaring inflation and rising interest rates pushed investors out of risky assets. And within digital health, there's been practically no IPO activity.
Hinge, founded in 2014, uses software to help patients treat acute musculoskeletal injuries and chronic pain, as well as carry out post-surgery rehabilitation remotely.
The stock opened at $39.25 on Thursday, rising 23% from its $32 IPO price. It closed up 17% at $37.56 a share, bringing its market capitalization to more than $3 billion. As of Wednesday afternoon, shares are trading at more than $41.
Prior to its IPO, Hinge had raised more than $1 billion from investors including Insight Partners, Atomico, Tiger Global Management and Coatue Management.
Most analysts will officially kick off coverage of the stock around 30 days after its debut. But analysts at Roth shared some initial thoughts about Hinge earlier this month, before it went public. Importantly, they did not participate in the offering, make a recommendation or initiate coverage in their report.
"We watched HNGE's IPO roadshow presentation and were impressed by the AI products underpinning the platform and rate of care expansion," including beyond musculoskeletal conditions, the analysts said in a note on May 16.
Hinge said that revenue in its first quarter climbed 50% to $123.8 million, up from $82.7 million during the same period last year. The company reported $117.3 million in revenue during its fourth quarter, up 44% from the same period in 2023.
The Roth analysts said the company's recent fundamentals are encouraging, including its accelerating revenues and billings as well as its improved operating margins. Some of the risks facing the company include the competitive digital therapy landscape, its reliance on peer-reviewed data and regulatory overhang, they said.
After Hinge's debut, another digital health company is preparing to join the fray. Omada Health filed for an IPO earlier this month, though it has yet to share more details about its expected pricing or timeline.
Omada offers virtual care programs to support patients with chronic conditions like prediabetes, diabetes and hypertension.
As we did with Hinge, we'll be following this offering closely, so stay tuned for updates!
Feel free to send any tips, suggestions, story ideas and data to Ashley at ashley.capoot@nbcuni.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
32 minutes ago
- Newsweek
Mushroom Recall Sparks Nationwide Warning to Customers
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Hofood99 Inc. is recalling packages of their Enoki Mushrooms due to fears the product may be contaminated with listeria. Newsweek reached out to the company via phone for additional comment on Wednesday and left a voicemail. Why It Matters Numerous recalls have been initiated this year due to the potential for the following: damaged products, foodborne illness, contamination and undeclared food allergens. Millions of Americans experience food sensitivities or food allergies every year. According to the Food and Drug Administration (FDA), the nine "major" food allergens in the U.S. are eggs, milk, fish, wheat, soybeans, Crustacean shellfish, sesame, tree nuts and peanuts. The FDA warns that Listeria monocytogenes is an organism that could cause serious and sometimes fatal infections in frail or older people, young children and those with weakened immune systems. Listeria could also lead to stillbirths or miscarriages in pregnant women, the FDA says. What To Know According to the FDA alert, the mushrooms were distributed nationwide to stores and retailers. The recalled mushrooms are sold in 200-gram green plastic packaging with a with UPC Barcode of 6 976532 310051 seen on the back label. No illnesses or injuries have been reported related to the recalled mushrooms. The mushrooms were distributed by Hofood99 Inc., located at 21903 56th Avenue Oakland Gardens, New York 11364. Recalled packages of Enoki Mushroom from Hofood99 Inc. can be seen in a June 11, 2025, recall alert. (Photo from the U.S. Food and Drug Administration) Recalled packages of Enoki Mushroom from Hofood99 Inc. can be seen in a June 11, 2025, recall alert. (Photo from the U.S. Food and Drug Administration) What People Are Saying The FDA in the alert in part: "The contamination was discovered after samples were collected from a store in Michigan and subsequent analysis by Michigan Department of Agriculture & Rural Development (MDARD) Laboratory Division revealed the presence of Listeria monocytogenes." In an email to Newsweek in January, the FDA said: "Most recalls in the U.S. are carried out voluntarily by the product manufacturer and when a company issues a public warning, typically via news release, to inform the public of a voluntary product recall, the FDA shares that release on our website as a public service. "The FDA's role during a voluntary, firm-initiated, recall is to review the recall strategy, evaluate the health hazard presented by the product, monitor the recall, and as appropriate alert the public and other companies in the supply chain about the recall," the FDA continued. It added: "The FDA provides public access to information on recalls by posting a listing of recalls according to their classification in the FDA Enforcement Report, including the specific action taken by the recalling company. The FDA Enforcement Report is designed to provide a public listing of products in the marketplace that are being recalled." Additional information on recalls can be found via the FDA's Recalls, Market Withdrawals, & Safety Alerts. What Happens Next Customers who have purchased the recalled mushrooms may return the product to the original place of purchase for a full refund or destroy it, the FDA says. People with additional questions may contact the company at (917) 756-9833 weekdays from 9 a.m. to 2 p.m.
CNN
41 minutes ago
- CNN
Kennedy names new members of CDC vaccine advisory panel days after removing previous advisers
Just two days after retiring the entirety of the US Centers for Disease Control and Prevention's vaccine advisory panel, US Health and Human Services Secretary Robert F. Kennedy Jr. has appointed several prominent critics of the government's Covid-19 response to that committee. He announced eight new members of the CDC's Advisory Committee on Immunization Practices, or ACIP, on Wednesday. Kennedy had said Monday that the previous 17-member panel that makes recommendations on who should get vaccines and when was rife with conflicts of interest and that he would appoint new 'highly credentialed' experts in time for the panel's June 25 meeting, at which the members are expected to discuss guidance for Covid-19 and HPV shots, among others. In a statement Wednesday, Kennedy said the reassembled panel will demand 'definitive safety and efficacy data before making any new vaccine recommendations, but will also review data for the current vaccine schedule as well.' The eight new ACIP members include Dr. Robert Malone, a biochemist who made early innovations in the field of messenger RNA but in more recent years has been a vocal critic of mRNA technology in Covid-19 vaccines. The CDC recently narrowed its recommendations for mRNA Covid-19 shots, but some advocates in the Make America Healthy Again space have pressed Kennedy to go further and bar the vaccines entirely. Another new member is Dr. Martin Kulldorff, a biostatistician and epidemiologist who co-authored an October 2020 strategy on herd immunity known as the Great Barrington Declaration with Dr. Jay Bhattacharya, now director of the US National Institutes of Health. Both Malone's and Kulldorff's names were circulated early in the second Trump administration as potential advisers on ACIP or other panels, according to a person familiar with the process who requested anonymity because they weren't authorized to speak with CNN. Kennedy also chose Dr. James Pagano, an emergency medicine physician he described as a 'strong advocate for evidence-based medicine' who has served on hospital committees and medical executive boards. Dr. Retsef Levi, an MIT professor who has published studies on mRNA vaccines and cardiovascular events, is also joining the panel. Levi is a professor of operations management. Several of the new members have served in federal health agencies previously, including Dr. Joseph Hibbeln, a former acting chief of the NIH's section on nutritional neurosciences. Dr. Cody Meissner, a Dartmouth professor of pediatrics who also signed the Great Barrington Declaration, has previously served on ACIP and on the US Food and Drug Administration's Vaccines and Related Biological Products Advisory Committee. Dr. Vicky Pebsworth, the Pacific region director of the National Association of Catholic Nurses, also served on the FDA committee and on a national panel reviewing the 2009 H1N1 swine flu vaccine. Dr. Michael Ross, a professor of obstetrics and gynecology at George Washington University and Virginia Commonwealth University, has previously served on the CDC's Advisory Committee for the Prevention of Breast and Cervical Cancer. Kennedy also nodded in his statement to Ross' 'continued service on biotech and healthcare boards.' The private equity company Havencrest, in which Ross is an operating partner, describes him on its site as a 'serial CEO' who has served on the boards of several biotechnology companies.
Yahoo
an hour ago
- Yahoo
DPH chief: Mass. prepared to maintain vaccine access
BOSTON (SHNS) – The state public health chief called the firing of all 17 members of a federal vaccine advisory panel 'troubling' on Wednesday, while acknowledging that Massachusetts officials have been bracing for such a scenario. On Monday, U.S. Health and Human Services Secretary Robert Kennedy Jr. dismissed all members of the CDC's Advisory Committee for Immunization Practices, or ACIP. President Joe Biden's administration had appointed all 17 members, including 13 in 2024, and 'these appointments would have prevented the current administration from choosing a majority of the committee until 2028,' Kennedy's office said. 'In dismissing the members, the secretary stated his intention to repopulate the committee and to hold the scheduled ACIP meeting June 25 to June 27,' Public Health Commissioner Robbie Goldstein said. 'This news is troubling. It amends a science-based process that has informed vaccine recommendations and promoted vaccine access for decades. The future of federal vaccine policy is unclear.' In a statement Monday, Kennedy said the move was 'necessary to reestablish public confidence in vaccine science.' New members were not announced but Kennedy's office said they will 'ensure that government scientific activities are informed by the most credible, reliable, and impartial scientific evidence available.' At a virtual state Public Health Council meeting Wednesday, Goldstein said it's unclear if new ACIP members 'will continue to use evidence and science to guide our vaccine recommendations and vaccine policy.' 'We've been been preparing for a number of scenarios, including this one, and we are well positioned to respond and maintain access to vaccines across the state,' Goldstein said. 'Starting in November, we've been analyzing the legal and regulatory landscape, identifying resources that could be used to guide vaccine recommendations, strengthening our data systems to understand vaccine effectiveness, and building a coalition of like-minded, evidence-based public health organizations in this state and others.' The Massachusetts Vaccine Purchasing Advisory Council, which helps distributes vaccines recommended by the ACIP, is slated to meet Thursday in Waltham. At a public hearing on Friday, Massachusetts parents and medical providers urged state lawmakers to scrap religious exemptions for school immunization requirements. The plea came amidst measles outbreaks in the U.S. Meanwhile, vaccine opponents lamented potential state infringements on their faith and personal beliefs. Students from preschool to college are required to receive a bevy of vaccines, including for polio, Hepatitis B, and measles, mumps and rubella, according to the state Department of Public Health. State law allows students to seek medical and religious exemptions, and refiled bills from Rep. Andy Vargas and Sen. Edward Kennedy (H 2544 / S 1557) would eliminate the religious carveout for immunizations required in public, private and charter K-12 schools. Under the proposals, schools must submit data annually to DPH about how many students are vaccinated and how many received a medical exemption — with that information then made publicly available. 'Three of our Northeast neighbors — Connecticut, Maine and New York — have eliminated their non-medical vaccine exemptions in recent years,' Katie Blair, executive director of Massachusetts Families for Vaccines, told the Joint Committee on Public Health. 'They have seen subsequent improvements in immunization rates, increasing the herd immunity protection that their most medically vulnerable residents depend upon. It's time for Massachusetts to do the same.' The committee reported the legislation out favorably at the end of last session on Dec. 16. Democrats in the Health Care Financing Committee did not advance the proposal. The majority of vaccine exemptions are for religious reasons in Massachusetts, according to DPH. Some western and southeastern parts of the state, especially on the Cape and Islands, have higher rates of vaccine exemptions, and those areas 'may be more susceptible to disease outbreaks because these students are not fully protected,' DPH says. Kyle Abrahamson, a biomedical engineer, said he opposed the bills because they encroach on his 'free exercise of religion' and constitute 'tyrannical overreach' from state government. Abrahamson argued that removing the religious exemption would force him to choose between his faith and his child's education. He also spoke against Sen. Becca Rausch's so-called Community Immunity Act (S 1618) that would preserve religious vaccine exemptions but strengthen the exemption process and improve data reporting. 'Parents — not the state, nor any medical professional or anybody else — but parents are the paramount advocates for their own children,' Abrahamson said. 'If H 2554, S 1557 and S 1618 move forward, the state is taking away parents' faith and forcing parents to put their faith in them.' Julie Booras, co-founder of Health Rights Massachusetts, said she 'strongly' opposes all school-related vaccine bills before the committee. She testified in support of a Rep. John Gaskey bill (H 2431) that would block the state from requiring COVID-19 shots, mRNA vaccines or gene-altering procedures to enroll in K-12 schools, colleges or universities, as well as to enter private businesses or seek employment. 'This bill is critical to ensure the injustices of the COVID era can never happen again,' Booras said. 'Despite all of the information now available about the physical, emotional and financial harms caused by the COVID countermeasures, nothing has changed. No meaningful action has been taken to rein in the sweeping powers granted to the governor and public health agencies by the Massachusetts Legislature.' Vaccine supporters had emphasized new urgency over removing religious exemptions as they invoked the worsening measles outbreak in Texas and other hotspots. Texas has logged 744 measles cases since January, causing 96 people to be hospitalized and two deaths among school-aged children, according to the Texas Department of State Health Services. There were 1,168 confirmed measles cases and three confirmed deaths across the U.S. as of June 5, according to the latest data from the Centers for Disease Control and Prevention. Massachusetts has not recorded any cases. 'Measles is an awful disease with dangerous complications and side effects,' Dr. Richard Moriarty, a retired pediatric infectious disease specialist, said. 'With cuts in health care funding, how are we going to pay if there are outbreaks? Outbreaks are very expensive.' Moriarty did not specify the funding cuts, but the Trump administration has moved to slash billions of dollars in public health grants and congressional Republicans are advancing proposals to drastically cut Medicaid dollars to states. 'Measles is so infectious, we need 95% of a population immunized to prevent an outbreak,' Moriarty continued. 'We thought our schools were good in Massachusetts, but if you take a deep dive into them, 119 kindergartens have MMR rates less than 90%, 31 schools are below 80% in Massachusetts, 19% of our schools didn't even bother to report their immunization rates this year, and 24% report their rates only on rolling three-year averages.' Supporters emphasized that vaccine skepticism and misinformation is more common across the country, and the landscape is also marked by shifting federal vaccine recommendations and immunization schedules. 'My colleagues are spending so much time just re-educating parents who have trusted the medical system for years and now have been instilled with this fear, which is completely based on misinformation,' said Dr. Christina Hermos, division chief of infectious disease at UMass Memorial Children's Medical Center. 'The frontline pediatricians are burning out having these conversations. We're already having a crisis of people going into primary care across this nation.' Kennedy last month announced the CDC is no longer recommending COVID vaccines for healthy children and pregnant individuals. Goldstein on Wednesday said that COVID vaccines remain available. He stressed that vaccinating pregnant women can protect newborn babies who cannot get immunized yet. 'I want to be clear: We know that COVID vaccination prevents severe illness, hospitalization and death in those at risk, which includes children and pregnant people,' Goldstein said. 'DPH will continue to lift up the data and the evidence that are available to inform our recommendations. And we'll work with insurers, health care providers and others across the state to maintain access to evidence-based safe vaccines.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
